Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|June 19, 2009
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplantPaul M Barr, Hillard M Lazarus, Brenda W Cooper, et al.
Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 28, 2020
Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation SurvivorsNosha Farhadfar, Debra L Kelly, Lacey Mead, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Transplantation and Cellular Therapy|April 6, 2021
Shorter Interdonation Interval Contributes to Lower Cell Counts in Subsequent Stem Cell DonationsSandhya R Panch, Brent Logan, Jennifer A Sees, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 6, 2010
Comparison of short-term response and long-term outcomes after initial systemic treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Paul A Carpenter, et al.
Transplantation and Cellular Therapy|April 18, 2021
The Effect of Donor Graft Cryopreservation on Allogeneic Hematopoietic Cell Transplantation Outcomes: A Center for International Blood and Marrow Transplant Research Analysis. Implications during the COVID-19 PandemicJack W Hsu, Nosha Farhadfar, Hemant Murthy, et al.
Blood|July 2, 2014
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCTCorey Cutler, Brent Logan, Ryotaro Nakamura, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTRGregory A Hale, Smriti Shrestha, Jennifer Le-Rademacher, et al.
American Journal of Hematology|January 6, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemiaGuru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait, et al.
Pageof 5